Sign In
Buy SAN
$14.10
-0.0100 (-0.0709%)
At Close: Jul 31, 2026
Santander calls on government and industry to tackle APP fraud
10:42am, Monday, 24'th Oct 2022
Santander has called on the government, banking industry and relevant bodies to tackle authorised push payment (APP) fraud. APP is when a scammer deceives a payer into making a payment, with over 70%
Better Buy: Ripple vs. Shiba Inu
11:41am, Tuesday, 18'th Oct 2022 The Motley Fool
These popular cryptocurrencies look ready to bounce back from the last year's brutal price cuts, but each one faces unique challenges.
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Septembre 2022
07:58pm, Thursday, 13'th Oct 2022 GlobeNewswire Inc.
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marc
Sanofi: Information concerning the total number of voting rights and shares - September 2022
07:58pm, Thursday, 13'th Oct 2022 GlobeNewswire Inc.
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement
Strength Seen in Bank Hapoalim (BKHYY): Can Its 9.3% Jump Turn into More Strength?
11:26am, Thursday, 13'th Oct 2022 Zacks Investment Research
Bank Hapoalim (BKHYY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down
Lloyds, NatWest, Barclays other banks slide as Santander warns of increased provisions
08:22am, Tuesday, 11'th Oct 2022
Shares in Lloyds Banking Group PLC (LSE:LLOY) and other FTSE 100 lenders slumped back towards recent lows on worries about potential bad debts and a bank windfall tax. A report emerged that Santander
Des données de phase III de dernière heure relatives à Dupixent® (dupilumab) présentées à la Semaine UEG 2022 montrent une rémission histologique significative de l’œsophagite à éosinophi
Press Release: Dupixent® (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic esophagitis (EoE) in children 1 to 11 years old
05:00am, Tuesday, 11'th Oct 2022 GlobeNewswire Inc.
Dupixent® (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic esophagitis (EoE) in children 1 to 11 years old
Why Shares of Banco Santander Brasil, Banco Bradesco, and Itau Unibanco Holding Are Rising Today
02:36pm, Monday, 03'rd Oct 2022
Investors are reacting to the results of the first round of Brazil's presidential election.
Banco Santander: Trading At Less Than 0.6 Times TBV And 5 Times Earnings
11:30am, Thursday, 29'th Sep 2022
Banco Santander is a Spanish bank, but generates most of its income from abroad. The share price has been sliding as recession fears are hitting the world economy.
Press Release: Dupixent® (dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis
10:05pm, Wednesday, 28'th Sep 2022 GlobeNewswire Inc.
Dupixent® (dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis
Communiqué de presse: Dupixent® (dupilumab), premier et seul médicament approuvé par la FDA pour le traitement du prurigo nodulaire
10:05pm, Wednesday, 28'th Sep 2022 GlobeNewswire Inc.
Dupixent® (dupilumab), premier et seul médicament approuvé par la FDA pour le traitement du prurigo nodulaire
Communiqué de presse : Mise en ligne du document «Q3 2022 Memorandum for modelling purposes»
05:30am, Wednesday, 28'th Sep 2022 GlobeNewswire Inc.
Mise en ligne du document «Q3 2022 Memorandum for modelling purposes»
Press Release: Availability of the Q3 2022 Memorandum for modelling purposes
05:30am, Wednesday, 28'th Sep 2022 GlobeNewswire Inc.
Availability of the Q3 2022 Memorandum for modelling purposes
'Some companies are closing their doors, others are shutting down divisions': Rocket CEO outlines plans to navigate the dramatic decline in mortgages
01:52pm, Saturday, 24'th Sep 2022 MarketWatch
Rocket, which owns Rocket Mortgage, Rocket Money, and more, is planning to diversify its approach to reach more consumers, on top of offering discounts to lower monthly payments.
